Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2013

Open Access 01-11-2013 | Meeting abstract

P01-032 – Characterization of genetic-negative FMF

Authors: I Ben-Zvi, C Herskovizh, Y Kassel, A Livneh

Published in: Pediatric Rheumatology | Special Issue 1/2013

Login to get access

Excerpt

Up to 20 percent of FMF cohorts consist of patients fulfilling the diagnostic criteria of familial Mediterranean fever, yet carry no MEFV mutations (genetic-negative). The phenotype of these patients has been poorly characterized. …
Metadata
Title
P01-032 – Characterization of genetic-negative FMF
Authors
I Ben-Zvi
C Herskovizh
Y Kassel
A Livneh
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue Special Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-S1-A36

Other articles of this Special Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue

Meeting abstract

P02-002 - IL36RN mutations in patients with DITRA

Meeting abstract

PW01-007 – Colchicine brand switching in FMF patients

Meeting abstract

P02-023 - NLRP3 mosaicism as a cause of late-onset CAPS

Meeting abstract

P01-003 – Bleeding disorder in FMF

Meeting abstract

P02-029 - CAPS or SJIA

Meeting abstract

PW01-024 – Phenotypic analysis of a MEFV negative FMF cohort